Alexander Ivannikov

Dr. Alexander Ivannikov

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 March 2023 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
VPV. I. Podzolkov
V. I. Podzolkov
ABAnna E. Bragina
Anna E. Bragina
ATA. I. Tarzimanova
A. I. Tarzimanova
LVL. V. Vasilyeva
L. V. Vasilyeva
EOE. S. Ogibenina
E. S. Ogibenina
NDNatalya Druzhinina
Natalya Druzhinina
Aim. To assess the association of hypertension with the severe forms and fatal outcomes of Coronavirus disease 2019 (COVID-19).Material and Methods. This retrospective cohort study involved adult patients (≥18 years old), admitted to the University hospital №4 of Sechenov University (Moscow, Russia) between 08 April 2020 and 19 November 2020 with clinically diagnosed or laboratory-confirmed COVID-19. The cohort included 1637 patients. The primary outcome was all-cause in-hospital mortality. The secondary outcomes included intensive care unit admission (ICU) and invasive ventilation. Multiple logistic regression was performed to assess the independent association between risk factors and endpoints.Results. A total of 1637 patients were included in the study. 51.80% (n=848) of the subjects were males. The median age was 59.0 (48.0; 70.0) years and 55.90% (n=915) had pre-existing diagnosis of hypertension. Patients with hypertension had significantly more severe lung injury based on chest CT scan findings as well as lower oxygen saturation (SрO2). More of them were admitted to ICU and placed on invasive ventilation. The hypertension group also had higher mortality. Age, hypertension, glucose, C-reactive protein and decreased platelet count were independently associated with mortality, hypertension having the strongest association (OR 1.827, 95% CI 1.174-2.846, p=0.008). Age, hypertension, neutrophil count, platelet count, glucose, and CRP were independently associated with ICU admission, with hypertension having the strongest association (OR 1.595, 95% CI 1.178-2.158, p=0.002). Age, hypertension, glucose, CRP and decreased platelet count were independently associated with invasive ventilation, with hypertension having the strongest association (OR 1.703, 95% CI 1.151-2.519, p=0.008).Based on the multiple logistic regression models, odds of death, ICU admission, and invasive ventilation were higher in the hypertension group as compared to the group without hypertension.Conclusion. Hypertension can be an independent predictor of severe COVID-19 and adverse outcomes, namely death, ICU admission, and invasive ventilation in hospitalized patients.

24 August 2021 in Russian Sklifosovsky Journal "Emergency Medical Care"
Verified
Journal Article
Open access
PDF file
AIAlexander Ivannikov
Alexander Ivannikov
AEA. N. Esaulenko
A. N. Esaulenko
MVM. K. Vasilchenko
M. K. Vasilchenko
KAKh. G. Alidzhanova
Kh. G. Alidzhanova
SPS. S. Petrikov
S. S. Petrikov
Ong-term consequences of COVID-19 remain the subject of active research interest. In this article the Post-COVID-19 syndrome (PCS) main features and symptoms are considered, its incidence and link with comorbidity is presented and the possible mechanisms are discussed. Due to the damage COVID-19 has on lungs, heart, brain and other systems, patients with PCS require multidisciplinary management.

20 April 2021 in Russian Sklifosovsky Journal "Emergency Medical Care"
Verified
Journal Article
Open access
PDF file
SPS. S. Petrikov
S. S. Petrikov
AIAlexander Ivannikov
Alexander Ivannikov
MVM. K. Vasilchenko
M. K. Vasilchenko
AEA. N. Esaulenko
A. N. Esaulenko
KAKh. G. Alidzhanova
Kh. G. Alidzhanova
COVID-19 и сердечно-сосудистая система. Часть 1. Патофизиология, патоморфология, осложнения, долгосрочный прогноз

12 January 2022 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Open access
PDF file
VPV. I. Podzolkov
V. I. Podzolkov
ATA. I. Tarzimanova
A. I. Tarzimanova
ABAnna E. Bragina
Anna E. Bragina
ISI. I. Shvedov
I. I. Shvedov
EBE. E. Bykova
E. E. Bykova
LVL. V. Vasilyeva
L. V. Vasilyeva
Aim. To evaluate the effect of sinus tachycardia and reduced left ventricular ejection fraction (LVEF) on the prognosis of patients with a verified diagnosis of a new coronavirus infection SARS-CoV-2.Material and methods. The study included 1,637 patients with a verified diagnosis of a new coronavirus infection SARS-CoV-2. The average age of the patients was 58.8±16.1 years. More than half of the patients admitted to the hospital had a history of cardiovascular diseases: hypertension was diagnosed in 915 (56%) patients, coronary artery disease – in 563 (34%), chronic heart failure – in 410 (25%). 294 (17.9%) patients suffered from diabetes mellitus. The unfavorable course of new coronavirus infection was assessed by the fact of being in the intensive care unit (ICU), the use of mechanical ventilation and death.Results. An unfavorable course of coronavirus infection was observed in 160 (9.8%) patients. Statistical analysis revealed that 341 (20.8%) patients with COVID-19 were diagnosed with sinus tachycardia, which required the appointment of pulse-reducing therapy. The occurrence of sinus tachycardia in patients with COVID-19 significantly increased the risk of death (odds ratio [OR] 1.248, confidence interval [CI] 1.038-1.499, p=0.018), increased the likelihood of mechanical ventilation use (OR 1.451, CI 1.168-1.803, p<0.001) and stay in the ICU (OR 1.440, CI 1.166-1.778, p<0.001).In 97 (5.9%) patients during hospital stay during echocardiography, a decrease in LVEF of less than 50% was diagnosed. A decrease in myocardial contractile function in patients with COVID-19 with high reliability increased the risk of death (OR 1.744, CI 1.348-2.256, p<0.001), increased the likelihood of using the mechanical ventilation (OR 1.372, CI 1.047-1.797, p=0.022) and stay in the ICU (OR 1.360, CI 1.077-1.716, p=0.010).Conclusion. The appearance of sinus tachycardia and reduced LVEF are in dependent predictors of the unfavorable course of COVID-19 in relation to factors such as death, the use of mechanical ventilation and the stay of patients in the ICU. Early pharmacological correction of cardiovascular lesions should be one of the goals of the management theese patients.

17 August 2023 in Rational Pharmacotherapy in Cardiology
Verified
Journal Article
Closed access
VPV. I. Podzolkov
V. I. Podzolkov
NDN. A. Dragomiretskaya
N. A. Dragomiretskaya
ATA. V. Tolmacheva
A. V. Tolmacheva
ISI. I. Shvedov
I. I. Shvedov
AIAlexander Ivannikov
Alexander Ivannikov
IAI. V. Akyol
I. V. Akyol
Aim. To study the prognostic significance of cardiobiomarkers - NT-proBNP and soluble suppression of tumorigenecity (sST2) in patients with CHF with preserved (CHFpEF) and mildly reduced EF (CHFmrEF).Material and methods. Along with a clinical examination, 207 patients (111 men and 96 women), mean age - 72.6 ± 11.4 years, underwent tests for the level of NT-proBNP and sST2 in serum. All patients were divided into 3 groups: 1 - CHFpEF (n=85), 2 - CHFmrEF (n=50); 3 (comparison group)- CHFrEF (n=72). All patients signed informed consent to participate in the study. The primary endpoint was all-cause death in 12 months. Statistical processing of the results was carried out using the Statistica 12.0 and Medcalc programs.Results. The initial values ​of NT-proBNP in patients with CHFmrEF were 691.9 [248; 1915.5] pg/ml and were significantly higher than those of CHFpEF - 445.8 [214.6; 945.7] pg/ml, but significantly lower than in CHFrEF - 1131.4 [411.5;3039.5] pg/ml, p<0.05. sST2 values ​​in group 1 (23.21 [12.17;48.7] ng/ml and group 2 (27.11 [16.98;53.76] ng/ml) did not differ, but were significantly lower than in patients with CHFrEF (44.6 [21.1; 93.5] ng/ml). After a median of 12 months 51 patients reached the primary endpoint. All-causes mortality in patients with HFpEF was 11.8%, HFmrEF - 31.9% (p <0.05), and HFrEF – 36%. A retrospective analysis of the data showed that in patients independent of their initial ejection fraction, who survived for 12 months, the levels of NT-proBNP and sST2 were significantly lower than those of the deceased. In survivors and deceased patients with CHFpEF the values ​​of NT-proBNP and sST2 were 443 [154;862,8] vs 1143,2 [223,9;2021,9] pg/ml (p=0.009) and 22,8 [12,3;33,8] vs 26,8 [9,6;74,8] ng/mL (p0.05). At ROC analysis to one-year adverse events, both NT-proBNP and sST2 showed a significant predictive value in patients with EF >40% with an optimal cut-off value of 746 pg/ml (AUC 0.709; p = 0.005, sensitivity 62%, specificity 69%) and 27.1 ng/ml (AUC 0.742; p = 0.03, sensitivity 80%, specificity 75.8%) respectively.Conclusion: NT-proBNP levels >746 pg/ml and sST2 >27.1 ng/ml should be considered as predictors of poor prognosis in CHF patients with LVEF >40%.

9 August 2022 in Russian Journal of Cardiology
Verified
Journal Article
Open access
PDF file
VPV. I. Podzolkov
V. I. Podzolkov
ATA. I. Tarzimanova
A. I. Tarzimanova
ABAnna E. Bragina
Anna E. Bragina
ILIrakli Loriya
Irakli Loriya
APA. E. Pokrovskaya
A. E. Pokrovskaya
DVD. D. Vanina
D. D. Vanina
Early diagnosis of atrial fibrillation (AF) predictors in coronavirus disease 2019 (COVID-19) and the appointment of additional therapy to prevent arrhythmias will improve the prognosis of patients.Aim. To identify predictors of AF in patients with COVID-19.Material and methods. This retrospective study included 1473 patients hospitalized with COVID-19. Depending on AF occurrence, the patients were divided into 2 groups as follows: group I included 95 patients with AF episodes during hospitalization; group II consisted of 1378 patients who did not have AF during hospitalization. All patients underwent a complete blood count and urine tests, a biochemical and coagulation blood tests, 12-lead electrocardiography, chest computed tomography (CT), and echocardiography.Results. Chest CT found that lung tissue involvement in patients of group I was significantly greater than in group II (p50% (CT-3 and CT-4) was significantly higher in the AF group than in the control group. The average room air oxygen saturation upon admission to the hospital were significantly lower in patients with AF than in the comparison group (p60 years, hypertension, coronary artery disease, heart failure, increased left atrial volume, large lung tissue involvement, and increased interleukin- 6 level.Conclusion. There are two following groups of predictors initiating AF in COVID-19: generally known (older age, cardiovascular disease, increased left atrial volume) and those that determine the severe COVID-19 course (large lung damage and high interleukin-6 levels).